|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 47/68 | |
| C07K 16/30 | |||
| A61K 31/4745 | |||
| A61K 31/708 | |||
| A61K 31/4375 | |||
| A61K 45/00 | |||
| A61P 35/00 |
| (11) | Patento numeris | 3189082 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15839010.4 |
| Europos patento paraiškos padavimo data | 2015-08-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-07-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-08-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2015/088456 |
| Data | 2015-08-29 |
| (87) | Numeris | WO 2016/034085 |
| Data | 2016-03-10 |
| (30) | Numeris | Data | Šalis |
| 201410440824 | 2014-09-01 | CN |
| (72) |
LI, Lixin, CN
LAU, Walter, CN
|
| (73) |
Birdie Biopharmaceuticals Inc.,
Sertus Chambers P.O. Box 2547 Cassia Court Camana Bay, Grand Cayman,
KY
|
| (54) | ANTI-PD-L1 CONJUGATES FOR TREATING TUMORS |
| ANTI-PD-L1 CONJUGATES FOR TREATING TUMORS |